Publication | Closed Access

Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats

InflammationFibrosisSclerostinMedicineLiver PhysiologyInduced Liver FibrosisPathologyHepatotoxicityPharmacotherapyOsteopontin InhibitorHepatology FibrosisPharmacologyOsteoporosisOsteocalcinPotential ProphylacticDrug-induced Liver Injury